Cumberland Pharmaceuticals Reports Fourth Quarter And Full Year 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Cumberland Pharmaceuticals (CPIX) Reports Q4 EPS of $0.03
March 3, 2016 4:26 PM ESTCumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.03, versus $0.10 reported last year. Revenue for the quarter came in at $8.04 million, versus $9.33 million reported last year.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
... More


